Truth About Trans Youth Care in Europe; Alzheimer's Research Misconduct Accusation
This past week in healthcare investigations
Stay updated with breaking news from Cassava Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This past week in healthcare investigations
ATLANTA, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Cassava Sciences, Inc. (“Cassava” or “the Company”) (NASDAQ:...
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
A researcher whose work was integral to the development of the Alzheimer’s drug simufilam has been found by the City University of New York to have engaged in “egregious misconduct” involving more than 20 scientific papers, Science reported.
American investors have been taken for a trillion-dollar ride by naked short sellers, in what could turn out to be the biggest financial regulatory scandal in North American history